Medicare Enrolled
Dr. Rina Patel, M.D.
Medical Oncology · Palm Beach Gardens, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Rina Patel is a medical oncology specialist in Palm Beach Gardens, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 75,507 Medicare services across 3,168 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $19,341 from 94 pharmaceutical and/or device companies across 1092 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 29% volume in FL
$19,341 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 141631 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗75,507
Medicare services
Top 29% in FL for medical oncology
3,168
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,719 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 29,070 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 13,650 | $1 | $5 |
| Contrast dye for imaging (iodine-based) | 8,572 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 6,120 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 4,870 | $36 | $108 |
| Dexamethasone injection (steroid) | 2,134 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,088 | $8 | $29 |
| Blood draw (venipuncture) | 1,923 | $8 | $9 |
| Office visit, established patient (20-29 min) | 1,496 | $69 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,170 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 576 | $0 | $9 |
| Injection of additional new drug or substance into vein | 470 | $12 | $61 |
| Office visit, established patient (30-39 min) | 371 | $101 | $339 |
| Administration of chemotherapy into vein, 1 hour or less | 325 | $104 | $378 |
| Drug injection, under skin or into muscle | 254 | $11 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 198 | $16 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 188 | $51 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 179 | $23 | $84 |
| Administration of chemotherapy into vein, each additional hour | 177 | $23 | $79 |
| Infusion into a vein for hydration, each additional hour | 145 | $10 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 125 | $1 | $3 |
| Administration of additional new drug or substance into vein, 1 hour or less | 114 | $51 | $178 |
| Infusion into a vein for hydration, 31-60 minutes | 113 | $25 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 113 | $3 | $11 |
| New patient office visit (45-59 min) | 103 | $132 | $453 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 102 | $137 | $562 |
| Infusion, normal saline solution , 1000 cc | 98 | $2 | $7 |
| Ct scan of chest with contrast | 86 | $51 | $344 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 81 | $401 | $680 |
| CT scan of abdomen and pelvis with contrast | 79 | $179 | $550 |
| Red blood count automated, with additional calculations | 77 | $5 | $20 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 71 | $1 | $7 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 68 | $1,153 | $3,706 |
| Automated urinalysis | 58 | $2 | $8 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | $26 | $89 |
| New patient office visit (30-44 min) | 53 | $87 | $298 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 39 | $1 | $6 |
| Office visit, established patient, complex (40-54 min) | 31 | $143 | $474 |
| Nuclear medicine study whole body with ct scan | 23 | $1,145 | $3,706 |
| New patient office visit, complex (60-74 min) | 21 | $173 | $585 |
| CT scan of chest, without contrast | 18 | $39 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.3% high complexity
45.1% medium
8.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,341
Total received (2018-2024)
Avg $2,763/year across 7 years
Top 27% in FL for medical oncology
94
Companies
1,092
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,163 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,342
2023
$4,712
2022
$3,548
2021
$2,633
2020
$2,202
2019
$773
2018
$129
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,245
PFIZER INC.
$1,115
Celgene Corporation
$1,088
Novartis Pharmaceuticals Corporation
$964
Janssen Biotech, Inc.
$906
Daiichi Sankyo Inc.
$856
GENZYME CORPORATION
$800
E.R. Squibb & Sons, L.L.C.
$766
Seagen Inc.
$744
Merck Sharp & Dohme LLC
$738
GlaxoSmithKline, LLC.
$631
Incyte Corporation
$609
Astellas Pharma US Inc
$504
Lilly USA, LLC
$421
Takeda Pharmaceuticals U.S.A., Inc.
$417
Alexion Pharmaceuticals, Inc.
$365
Eisai Inc.
$353
Amgen Inc.
$313
Bayer Healthcare Pharmaceuticals Inc.
$287
SOBI, INC
$287
Bayer HealthCare Pharmaceuticals Inc.
$283
TerSera Therapeutics LLC
$255
ABBVIE INC.
$254
Ipsen Biopharmaceuticals, Inc
$238
TG THERAPEUTICS, INC.
$233
Genentech USA, Inc.
$229
Pharmacyclics LLC, An AbbVie Company
$211
BeiGene USA, Inc.
$208
PharmaEssentia USA Corporation
$195
EMD Serono, Inc.
$191
SERVIER PHARMACEUTICALS LLC
$178
ARRAY BIOPHARMA INC
$167
PUMA BIOTECHNOLOGY, INC.
$166
Deciphera Pharmaceuticals Inc.
$157
Kyowa Kirin, Inc.
$150
Rigel Pharmaceuticals, Inc.
$138
Phathom Pharmaceuticals, Inc.
$125
JAZZ PHARMACEUTICALS INC.
$113
Adaptive Biotechnologies Corporation
$110
Dova Pharmaceuticals
$102
Puma Biotechnology, Inc.
$102
La Jolla Pharmaceutical Company
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
Clovis Oncology, Inc.
$92
Global Blood Therapeutics, Inc.
$89
AVEO Pharmaceuticals, Inc.
$81
Pharmacosmos Therapeutics Inc.
$73
Taiho Oncology, Inc.
$72
Myriad Genetic Laboratories, Inc.
$72
Sun Pharmaceutical Industries Inc.
$70
Seattle Genetics, Inc.
$68
EISAI INC.
$68
Regeneron Healthcare Solutions, Inc.
$65
Exelixis Inc.
$61
Octapharma USA, Inc.
$59
RECORDATI_RARE_DISEASES_INC.
$58
Merck Sharp & Dohme Corporation
$58
Acceleron Pharma, Inc.
$50
Alnylam Pharmaceuticals Inc.
$47
Stemline Therapeutics Inc.
$42
TAIHO ONCOLOGY, INC.
$41
Pharmacyclics LLC, an AbbVie Company
$40
Coherus Biosciences Inc.
$39
EUSA Pharma (US) LLC
$37
Agios Pharmaceuticals, Inc.
$36
MorphoSys, US Inc.
$35
CTI BioPharma Corp.
$35
Acrotech Biopharma LLC
$35
Heron Therapeutics, Inc.
$31
Aurobindo Pharma USA, Inc.
$30
Sobi, Inc
$30
Spectrum Pharmaceuticals Inc.
$29
Foundation Medicine, Inc.
$29
Sumitomo Pharma America, Inc.
$29
Legend Biotech USA Inc.
$26
Acrotech Biopharma Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Mirati Therapeutics, Inc.
$22
Ferring Pharmaceuticals Inc.
$22
SpringWorks Therapeutics, Inc.
$22
Jazz Pharmaceuticals Inc.
$20
AbbVie Inc.
$19
Cumberland Pharmaceuticals, Inc.
$19
ImmunoGen, Inc.
$18
Secura Bio, Inc.
$16
GE HealthCare
$15
Kite Pharma, Inc.
$13
Fortovia Therapeutics, Inc.
$13
AbbVie, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Sirtex Medical Inc
$10
NOVARTIS PHARMACEUTICALS CORPORATION
$9
Organon LLC
$7
Veracyte, Inc.
$2
Top 3 companies account for 17.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · ALIMTA · ALUNBRIG · Aliqopa · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cerianna · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Elahere · Enhertu · FARYDAK · FIRMAGON · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GIAPREZA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYLVANT · Soltamox · Stivarga · Sylvant · TAGRISSO · TASIGNA · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tibsovo · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOQUEZNA · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $26 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
18
Per 100K population
1.2
County median income
$81,115
Nearest hospital
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 29,070 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $19,341 from 94 companies across 1,092 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other medical oncologists in Palm Beach Gardens?
Dr. Patel's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Palm Beach Gardens
Browse medical oncologists in Palm Beach Gardens ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology